89/100BAstera Labs stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Astera Labs is 363.36, 63.8% above the current price of 221.79. Their targets range from 275.00 to 500.00.
Of the 14 firms that rated Astera Labs in the past 12 months, 9 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 275.00 to 500.00, with an average of 363.36.
| Buy | 9 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 500.00 |
| Average target | 363.36 |
| Lowest target | 275.00 |
| Current price | 221.79 |
Astera Labs price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Astera Labs price target and rating?
How analysts rate Astera Labs, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 14 firms rate it buy now, against 11 of 14 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Astera Labs analyst upgrades, downgrades and price targets
The latest rating change came on 17 August 2026, when Northland Securities upgraded Astera Labs from Market Perform to Outperform. Its price target is 350.00, from 195.00. The most recent new target came from Northland Securities on 4 November 2026: 315.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 4 Nov 2026 | Northland Securities Gus Richard | — | 350.00 → 315.00 | -10.0% | 233.62 |
| 4 Nov 2026 | Needham Quinn Bolton | Reiterated · Buy | 425.00 → 300.00 | -29.4% | 233.62 |
| 4 Nov 2026 | UBS Timothy Arcuri | Reiterated · Neutral | 425.00 → 290.00 | -31.8% | 233.62 |
| 17 Aug 2026 | Northland Securities | Upgraded · Market Perform → Outperform | 195.00 → 350.00 | +79.5% | 321.61 |
| 5 Aug 2026 | Roth Capital Suji Desilva | — | 275.00 → 450.00 | +63.6% | 337.49 |
| 5 Aug 2026 | RBC Capital | Reiterated · Outperform | 270.00 → 500.00 | +85.2% | 361.67 |
| 5 Aug 2026 | UBS | — | 400.00 → 425.00 | +6.3% | 361.67 |
| 5 Aug 2026 | Needham Quinn Bolton | Reiterated · Buy | 260.00 → 425.00 | +63.5% | 361.67 |
| 5 Aug 2026 | Jefferies Blayne Curtis | Reiterated · Buy | 270.00 → 450.00 | +66.7% | 361.67 |
| 3 Aug 2026 | Morgan Stanley | — | 240.00 → 335.00 | +39.6% | 311.23 |
| 31 Jul 2026 | Susquehanna Mehdi Hosseini | Reiterated · Neutral | 230.00 → 275.00 | +19.6% | 299.69 |
| 20 Jul 2026 | Barclays Tom O'Malley | Reiterated · Equal Weight | 200.00 → 325.00 | +62.5% | 303.62 |
| 29 Jun 2026 | UBS | Reiterated · Neutral | 180.00 → 400.00 | +122.2% | 405.67 |
| 24 Jun 2026 | Stifel Nicolaus | Reiterated · Buy | 260.00 → 460.00 | +76.9% | 397.02 |
| 19 May 2026 | Evercore ISI | Reiterated · Outperform | 297.00 | — | 215.58 |
| 7 May 2026 | Barclays Tom O'Malley | Reiterated · Equal Weight | 165.00 → 200.00 | +21.2% | 213.91 |
| 6 May 2026 | Needham | Reiterated · Buy | 220.00 → 260.00 | +18.2% | 205.72 |
| 6 May 2026 | Susquehanna Mehdi Hosseini | Reiterated · Neutral | 80.00 → 230.00 | +187.5% | 209.19 |
| 6 May 2026 | Roth Capital | — | 100.00 → 275.00 | +175.0% | 205.66 |
| 6 May 2026 | RBC Capital | Reiterated · Outperform | 250.00 → 270.00 | +8.0% | 206.50 |
| 6 May 2026 | Stifel Nicolaus Tore Svanberg | Reiterated · Buy | 236.00 → 260.00 | +10.2% | 215.69 |
| 6 May 2026 | Morgan Stanley Joseph Moore | Reiterated · Overweight | 210.00 → 240.00 | +14.3% | 215.69 |
| 6 May 2026 | Jefferies | — | 270.00 | — | 215.69 |
| 1 May 2026 | Stifel Nicolaus Tore Svanberg | — | 200.00 → 236.00 | +18.0% | 194.74 |
| 1 May 2026 | Redburn Partners | — | 153.00 | — | 194.74 |
| 21 Apr 2026 | RBC Capital Srini Pajjuri | — | 225.00 → 250.00 | +11.1% | 175.80 |
| 21 Apr 2026 | UBS Natalia Winkler | — | 180.00 | — | 175.80 |
| 15 Jan 2026 | Barclays Tom O'Malley | — | 155.00 → 165.00 | +6.5% | 172.14 |
| 14 Jan 2026 | RBC Capital | — | 225.00 | — | 172.14 |
| 9 Dec 2025 | Northland Securities | Reiterated · Outperform | 175.00 → 195.00 | +11.4% | 167.63 |
| 3 Dec 2025 | Morgan Stanley Joseph Moore | — | 200.00 → 210.00 | +5.0% | 142.94 |
| 17 Nov 2025 | Northland Securities Gus Richard | Upgraded · Market Perform → Outperform | 175.00 | — | 142.88 |
Astera Labs EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Astera Labs beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 72.8% off the result, either way, and their revenue estimate 10.3%, over the last 11 quarters.
- EPS beats
- 11 / 11
- Revenue beats
- 9 / 11
- Average EPS surprise, last 11What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +72.8%
- Since
- May 2024
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 3 Nov 2026 | 1.19 | 1.32 | +10.9% | 550.78M | 584.90M | +6.2% |
| Q2 FY2026 | 4 Aug 2026 | 0.69 | 0.80 | +15.8% | 360.85M | 392.40M | +8.7% |
| Q1 FY2026 | 5 May 2026 | 0.54 | 0.61 | +13.6% | 292.19M | 308.36M | +5.5% |
| Q4 FY2025 | 10 Feb 2026 | 0.52 | 0.58 | +12.4% | 249.54M | 270.58M | +8.4% |
| Q3 FY2025 | 4 Nov 2025 | 0.39 | 0.49 | +25.7% | 206.46M | 230.58M | +11.7% |
| Q2 FY2025 | 5 Aug 2025 | 0.32 | 0.44 | +35.8% | 172.49M | 191.93M | +11.3% |
| Q1 FY2025 | 6 May 2025 | 0.28 | 0.33 | +16.2% | 153.10M | 159.44M | +4.1% |
| Q4 FY2024 | 10 Feb 2025 | 0.26 | 0.37 | +42.3% | 151.55M | 141.10M | -6.9% |
| Q3 FY2024 | 4 Nov 2024 | 0.17 | 0.23 | +34.8% | 97.50M | 113.09M | +16.0% |
| Q2 FY2024 | 6 Aug 2024 | 0.11 | 0.13 | +18.2% | 95.66M | 76.85M | -19.7% |
| Q1 FY2024 | 7 May 2024 | 0.01 | 0.10 | +575.2% | 56.70M | 65.26M | +15.1% |
Astera Labs stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Astera Labs's earnings grow at the 69.6% a year analysts expect to FY2028, then 15.0% a year, it would earn about 11.87 a share in FY2030. At the P/E of similar companies (Semiconductors, 22.5 to 59.9) that is 267.59 to 711.52 a share, or 457.99 at their average P/E of 38.6. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 4.29 | 96.72 | 165.54 | 257.18 |
| FY2027 | 7.06 | 159.06 | 272.24 | 422.94 |
| FY2028 | 8.97 | 202.34 | 346.31 | 538.02 |
| FY2029 (extrapolated) | 10.32 | 232.69 | 398.25 | 618.72 |
| FY2030 (extrapolated) | 11.87 | 267.59 | 457.99 | 711.52 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Its own P/E has been above 60, or from losses, too often in the last five years, so bear, base and bull apply the lowest, average and highest P/E of similar companies (Semiconductors: 22.5, 38.6, 59.9), those up to 60.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.760 | 71.4258Price 35.76193 | +99.7% | |
| 29.080 | 56.2434Price 29.0896 | +93.4% | |
| 240.360 | 464.26205Price 240.36627 | +93.2% | |
| 202.040 | 384.58163Price 202.042,644 | +90.3% | |
| 161.340 | 305.52160Price 161.34396 | +89.4% | |
| 125.395 | 237.44178Price 125.40297 | +89.4% | |
| 159.580 | 300.48225Price 159.58376 | +88.3% |
Furthest below the fair value on each stock's page, updated every day.